89 related articles for article (PubMed ID: 18802925)
1. Lysophosphatidic acid activates telomerase in ovarian cancer cells through hypoxia-inducible factor-1alpha and the PI3K pathway.
Yang K; Zheng D; Deng X; Bai L; Xu Y; Cong YS
J Cell Biochem; 2008 Dec; 105(5):1194-201. PubMed ID: 18802925
[TBL] [Abstract][Full Text] [Related]
2. VEGF- and LPA-induced telomerase in human ovarian cancer cells is Sp1-dependent.
Bermudez Y; Yang H; Saunders BO; Cheng JQ; Nicosia SV; Kruk PA
Gynecol Oncol; 2007 Sep; 106(3):526-37. PubMed ID: 17559911
[TBL] [Abstract][Full Text] [Related]
3. Activation of hypoxia-inducible factor-1alpha is necessary for lysophosphatidic acid-induced vascular endothelial growth factor expression.
Lee J; Park SY; Lee EK; Park CG; Chung HC; Rha SY; Kim YK; Bae GU; Kim BK; Han JW; Lee HY
Clin Cancer Res; 2006 Nov; 12(21):6351-8. PubMed ID: 17085645
[TBL] [Abstract][Full Text] [Related]
4. Gene regulatory networking reveals the molecular cue to lysophosphatidic acid-induced metabolic adaptations in ovarian cancer cells.
Ray U; Roy Chowdhury S; Vasudevan M; Bankar K; Roychoudhury S; Roy SS
Mol Oncol; 2017 May; 11(5):491-516. PubMed ID: 28236660
[TBL] [Abstract][Full Text] [Related]
5. 4-Hydroxy estradiol but not 2-hydroxy estradiol induces expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor A through phosphatidylinositol 3-kinase/Akt/FRAP pathway in OVCAR-3 and A2780-CP70 human ovarian carcinoma cells.
Gao N; Nester RA; Sarkar MA
Toxicol Appl Pharmacol; 2004 Apr; 196(1):124-35. PubMed ID: 15050414
[TBL] [Abstract][Full Text] [Related]
6. [Relationship between human telomerase reverse transcriptase transcriptional level and telomerase activity in three ovarian cancer cell lines].
Song Y; Kong BH; Liu PS; Ma DX; Jiang S
Ai Zheng; 2003 May; 22(5):486-91. PubMed ID: 12753708
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia enhances LPA-induced HIF-1alpha and VEGF expression: their inhibition by resveratrol.
Park SY; Jeong KJ; Lee J; Yoon DS; Choi WS; Kim YK; Han JW; Kim YM; Kim BK; Lee HY
Cancer Lett; 2007 Dec; 258(1):63-9. PubMed ID: 17919812
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of interleukin-6 in human ovarian cancer cell via a Gi/PI3K-Akt/NF-kappaB pathway by lysophosphatidic acid, an ovarian cancer-activating factor.
Chou CH; Wei LH; Kuo ML; Huang YJ; Lai KP; Chen CA; Hsieh CY
Carcinogenesis; 2005 Jan; 26(1):45-52. PubMed ID: 15471896
[TBL] [Abstract][Full Text] [Related]
9. The opposing effect of hypoxia-inducible factor-2alpha on expression of telomerase reverse transcriptase.
Lou F; Chen X; Jalink M; Zhu Q; Ge N; Zhao S; Fang X; Fan Y; Björkholm M; Liu Z; Xu D
Mol Cancer Res; 2007 Aug; 5(8):793-800. PubMed ID: 17699105
[TBL] [Abstract][Full Text] [Related]
10. Discoidin Domain Receptor 2 Mediates Lysophosphatidic Acid-Induced Ovarian Cancer Aggressiveness.
Jeong BY; Cho KH; Yoon SH; Park CG; Park HW; Lee HY
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065317
[TBL] [Abstract][Full Text] [Related]
11. HIF-1-mediated activation of telomerase in cervical cancer cells.
Yatabe N; Kyo S; Maida Y; Nishi H; Nakamura M; Kanaya T; Tanaka M; Isaka K; Ogawa S; Inoue M
Oncogene; 2004 Apr; 23(20):3708-15. PubMed ID: 15048086
[TBL] [Abstract][Full Text] [Related]
12. Lysophosphatidic acid stimulates epithelial to mesenchymal transition marker Slug/Snail2 in ovarian cancer cells via Gαi2, Src, and HIF1α signaling nexus.
Ha JH; Ward JD; Radhakrishnan R; Jayaraman M; Song YS; Dhanasekaran DN
Oncotarget; 2016 Jun; 7(25):37664-37679. PubMed ID: 27166196
[TBL] [Abstract][Full Text] [Related]
13. Induction of hTERT expression and phosphorylation by estrogen via Akt cascade in human ovarian cancer cell lines.
Kimura A; Ohmichi M; Kawagoe J; Kyo S; Mabuchi S; Takahashi T; Ohshima C; Arimoto-Ishida E; Nishio Y; Inoue M; Kurachi H; Tasaka K; Murata Y
Oncogene; 2004 Jun; 23(26):4505-15. PubMed ID: 15048073
[TBL] [Abstract][Full Text] [Related]
14. Role of decreased levels of lipid phosphate phosphatase-1 in accumulation of lysophosphatidic acid in ovarian cancer.
Tanyi JL; Hasegawa Y; Lapushin R; Morris AJ; Wolf JK; Berchuck A; Lu K; Smith DI; Kalli K; Hartmann LC; McCune K; Fishman D; Broaddus R; Cheng KW; Atkinson EN; Yamal JM; Bast RC; Felix EA; Newman RA; Mills GB
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3534-45. PubMed ID: 14506139
[TBL] [Abstract][Full Text] [Related]
15. [Hypoxia increases the expression of heparitinase and the invasiveness through the hypoxia inducible factor-1alpha dependent pathway in human ovarian cancer cell line SKOV3].
Yuan CX; Gu S; Zhang SH; Zhang XN
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Dec; 30(6):711-6. PubMed ID: 19180921
[TBL] [Abstract][Full Text] [Related]
16. Lysophospholipids increase interleukin-8 expression in ovarian cancer cells.
Schwartz BM; Hong G; Morrison BH; Wu W; Baudhuin LM; Xiao YJ; Mok SC; Xu Y
Gynecol Oncol; 2001 May; 81(2):291-300. PubMed ID: 11330965
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol attenuates norepinephrine-induced ovarian cancer invasiveness through downregulating hTERT expression.
Kim SH; Cho KH; Kim YN; Jeong BY; Park CG; Hur GM; Lee HY
Arch Pharm Res; 2016 Feb; 39(2):240-248. PubMed ID: 26428673
[TBL] [Abstract][Full Text] [Related]
18. Growth arrest in ovarian cancer cells by hTERT inhibition short-hairpin RNA targeting human telomerase reverse transcriptase induces immediate growth inhibition but not necessarily induces apoptosis in ovarian cancer cells.
Luo Y; Yi Y; Yao Z
Cancer Invest; 2009 Dec; 27(10):960-70. PubMed ID: 19909010
[TBL] [Abstract][Full Text] [Related]
19. Lysophosphatidic acid downregulates tissue inhibitor of metalloproteinases, which are negatively involved in lysophosphatidic acid-induced cell invasion.
Sengupta S; Kim KS; Berk MP; Oates R; Escobar P; Belinson J; Li W; Lindner DJ; Williams B; Xu Y
Oncogene; 2007 May; 26(20):2894-901. PubMed ID: 17130843
[TBL] [Abstract][Full Text] [Related]
20. Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells.
Braunstein I; Cohen-Barak O; Shachaf C; Ravel Y; Yalon-Hacohen M; Mills GB; Tzukerman M; Skorecki KL
Cancer Res; 2001 Jul; 61(14):5529-36. PubMed ID: 11454703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]